The diagnosis of ET is established based on the World Health Organization (WHO) criteria, which include elevated platelet counts, bone marrow biopsy findings, and the presence of a JAK2, CALR, or MPL mutation [5]. Here, JAK2 is linked to essential thrombocythemia.